Exact Mass: 503.2155

Exact Mass Matches: 503.2155

Found 14 metabolites which its exact mass value is equals to given mass value 503.2155, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

methyl (1S,2S,3R,5S,8R,9R,10R)-10-[(2R,3E,5E,7E)-7-(2,4-dioxopyrrolidin-3-ylidene)-7-hydroxy-4-methylhepta-3,5-dien-2-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.01,5]dodecane-2-carboxylate

methyl (1S,2S,3R,5S,8R,9R,10R)-10-[(2R,3E,5E,7E)-7-(2,4-dioxopyrrolidin-3-ylidene)-7-hydroxy-4-methylhepta-3,5-dien-2-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.01,5]dodecane-2-carboxylate

C26H33NO9 (503.2155)


   

(3aS)-5c-[(1R,2E,4E)-6-((E)-2,4-dioxo-pyrrolidin-3-ylidene)-6-hydroxy-1,3-dimethyl-hexa-2,4-dienyl]-2c,6t,9a-trimethyl-8-oxo-(9at)-octahydro-3ar,7c-epioxido-furo[3,2-b]oxocine-3c-carboxylic acid methyl ester|antibiotic Bu-2313-B|nocamycin-I

(3aS)-5c-[(1R,2E,4E)-6-((E)-2,4-dioxo-pyrrolidin-3-ylidene)-6-hydroxy-1,3-dimethyl-hexa-2,4-dienyl]-2c,6t,9a-trimethyl-8-oxo-(9at)-octahydro-3ar,7c-epioxido-furo[3,2-b]oxocine-3c-carboxylic acid methyl ester|antibiotic Bu-2313-B|nocamycin-I

C26H33NO9 (503.2155)


   

Nocamycin I

Nocamycin I

C26H33NO9 (503.2155)


An organic heterotricyclic compound and tetramic acid derivative originally isolated from an unidentified oligosporic actinomycete strain (no. E864-861) and found to be active against both Gram-positive and Gram-negative anaerobic bacteria as well as some aerobic bacteria such as Streptococci. The methyl ester of nocamycin E.

   

Trimebutine Maleate

Trimebutine Maleate

C26H33NO9 (503.2155)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D005765 - Gastrointestinal Agents Trimebutine maleate is an orally anti-tumor agent. Trimebutine maleate selectively suppresses stemness and proliferation of ovarian cancer stem cells (CSCs). Trimebutine maleate reduces the colonic muscle hypercontractility, modulates gastrointestinal motility, induces apoptosis and can be used for the research of glioma/glioblastoma and irritable bowel syndrome[1][2][3][4][5][6].

   

methyl (3R,5S,9R,10R)-10-[(2R,3E,5E,7Z)-7-(2,4-dioxopyrrolidin-3-ylidene)-7-hydroxy-4-methylhepta-3,5-dien-2-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.01,5]dodecane-2-carboxylate

methyl (3R,5S,9R,10R)-10-[(2R,3E,5E,7Z)-7-(2,4-dioxopyrrolidin-3-ylidene)-7-hydroxy-4-methylhepta-3,5-dien-2-yl]-3,5,9-trimethyl-7-oxo-4,11,12-trioxatricyclo[6.3.1.01,5]dodecane-2-carboxylate

C26H33NO9 (503.2155)


   

ST 24:6;O7;Gly

ST 24:6;O7;Gly

C26H33NO9 (503.2155)


   

ST 18:5;O4;HexNAc

ST 18:5;O4;HexNAc

C26H33NO9 (503.2155)


   

(1r,4r,8s,10r,12r,13s,16s,17r)-17,19-dihydroxy-13-(methoxymethyl)-8,12-dimethyl-2,7,15-trioxo-14-oxa-18-azapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),18-dien-10-yl 2-methylbutanoate

(1r,4r,8s,10r,12r,13s,16s,17r)-17,19-dihydroxy-13-(methoxymethyl)-8,12-dimethyl-2,7,15-trioxo-14-oxa-18-azapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),18-dien-10-yl 2-methylbutanoate

C26H33NO9 (503.2155)


   

(1r,4r,8s,10r,12r,13s,16s,17s)-17,19-dihydroxy-13-(methoxymethyl)-8,12-dimethyl-2,7,15-trioxo-14-oxa-18-azapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),18-dien-10-yl 2-methylbutanoate

(1r,4r,8s,10r,12r,13s,16s,17s)-17,19-dihydroxy-13-(methoxymethyl)-8,12-dimethyl-2,7,15-trioxo-14-oxa-18-azapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),18-dien-10-yl 2-methylbutanoate

C26H33NO9 (503.2155)


   

ethyl 4-[(1-{10-acetyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-5-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-4-yl}ethylidene)amino]butanoate

ethyl 4-[(1-{10-acetyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-5-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-4-yl}ethylidene)amino]butanoate

C26H33NO9 (503.2155)


   

methyl 2-{7-[(3e,5e)-7-(2-hydroxy-4-oxo-1,5-dihydropyrrol-3-yl)-4-methyl-7-oxohepta-3,5-dien-2-yl]-1,6-dimethyl-4-oxo-8,9-dioxaspiro[bicyclo[3.3.1]nonane-2,2'-oxiran]-3'-yl}propanoate

methyl 2-{7-[(3e,5e)-7-(2-hydroxy-4-oxo-1,5-dihydropyrrol-3-yl)-4-methyl-7-oxohepta-3,5-dien-2-yl]-1,6-dimethyl-4-oxo-8,9-dioxaspiro[bicyclo[3.3.1]nonane-2,2'-oxiran]-3'-yl}propanoate

C26H33NO9 (503.2155)


   

methyl 2-{7-[(3e,5e)-7-hydroxy-7-(2-hydroxy-4-oxo-5h-pyrrol-3-ylidene)-4-methylhepta-3,5-dien-2-yl]-1,6-dimethyl-4-oxo-8,9-dioxaspiro[bicyclo[3.3.1]nonane-2,2'-oxiran]-3'-yl}propanoate

methyl 2-{7-[(3e,5e)-7-hydroxy-7-(2-hydroxy-4-oxo-5h-pyrrol-3-ylidene)-4-methylhepta-3,5-dien-2-yl]-1,6-dimethyl-4-oxo-8,9-dioxaspiro[bicyclo[3.3.1]nonane-2,2'-oxiran]-3'-yl}propanoate

C26H33NO9 (503.2155)


   

ethyl 4-({1-[(2s,7r)-10-acetyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-5-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-4-yl]ethylidene}amino)butanoate

ethyl 4-({1-[(2s,7r)-10-acetyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-5-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-4-yl]ethylidene}amino)butanoate

C26H33NO9 (503.2155)


   

17,19-dihydroxy-13-(methoxymethyl)-8,12-dimethyl-2,7,15-trioxo-14-oxa-18-azapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),18-dien-10-yl 2-methylbutanoate

17,19-dihydroxy-13-(methoxymethyl)-8,12-dimethyl-2,7,15-trioxo-14-oxa-18-azapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),18-dien-10-yl 2-methylbutanoate

C26H33NO9 (503.2155)